TSE:4568Pharmaceuticals
Daiichi Sankyo (TSE:4568) Margin Improvement Supports Bullish Growth Narrative In Q3 2026
Daiichi Sankyo (TSE:4568) has reported another data heavy quarter for Q3 2026, with revenue of ¥558,106 million and basic EPS of ¥46.80, as investors weigh those headline figures against the share price around ¥2,836. The company’s revenue increased from ¥484,840 million in Q3 2025 to ¥558,106 million in Q3 2026, while basic EPS moved from ¥32.78 to ¥46.80 over the same period. This offers a clearer view of how the top line and per share earnings have tracked together. Overall, the latest...